theory clinical_107_4
imports Main


begin

typedecl entity
typedecl event

consts
  HER2Mutation :: "entity ⇒ bool"
  V777L :: "entity ⇒ bool"
  Overexpression :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Resulted :: "event ⇒ entity ⇒ bool"
  TrastuzumabResistance :: "entity ⇒ bool"
  Assay :: "entity ⇒ bool"
  SoftAgar :: "entity ⇒ bool"
  ColonyFormation :: "entity ⇒ bool"
  CancerCellLine :: "entity ⇒ bool"
  Colorectal :: "entity ⇒ bool"
  By :: "entity ⇒ entity ⇒ bool"
  Of :: "event ⇒ entity ⇒ bool"
  Tumors :: "entity ⇒ bool"
  Portion :: "entity ⇒ bool"
  Develop :: "event ⇒ bool"
  Ultimately :: "event ⇒ bool"
  Resistance :: "event ⇒ bool"
  AntiHER2AntibodyTherapy :: "event ⇒ bool"
  To :: "event ⇒ entity ⇒ bool"
  Patient :: "entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  Beneficiary :: "event ⇒ entity ⇒ bool"
  From :: "event ⇒ entity ⇒ bool"

(* Explanation 1: Overexpression of a HER2 V777L mutation resulted in trastuzumab resistance by a soft-agar colony formation assay of a colorectal cancer cell line. *)
axiomatization where
  explanation_1: "∃x y z w v e. HER2Mutation x ∧ V777L x ∧ Overexpression e ∧ Agent e x ∧ Resulted e y ∧ TrastuzumabResistance y ∧ Assay z ∧ SoftAgar z ∧ ColonyFormation z ∧ CancerCellLine w ∧ Colorectal w ∧ By y z ∧ Of e w"

(* Explanation 2: A portion of tumors, however, ultimately develop resistance to anti-HER2 antibody therapy. *)
axiomatization where
  explanation_2: "∃x y z. Tumors x ∧ Portion y ∧ Develop z ∧ Agent z y ∧ Ultimately z ∧ Resistance z ∧ AntiHER2AntibodyTherapy z ∧ To z y"

(* Explanation 3: Patient may benefit from treatment with Trastuzumab. *)
axiomatization where
  explanation_3: "∃x y z. Patient x ∧ Trastuzumab z ∧ Benefit e ∧ Agent e x ∧ Beneficiary e y ∧ From e z"


theorem hypothesis:
 assumes asm: "Patient x"
  (* Hypothesis: This patient may develop resistance to Trastuzumab therapy. *)
 shows "∃x y z. Patient x ∧ Resistance y ∧ Trastuzumab z ∧ Develop e ∧ Agent e x ∧ Patient e y ∧ To y z"
  sledgehammer
  oops

end
